Macular Degeneration Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities
Uncover key drivers, emerging technologies, and competitive movements shaping the macular degeneration treatment market from 2026–2035 with trusted insights from The Business Research Company
How is the Macular Degeneration Treatment Market size predicted to change over the forecast window of 2026–2035?
The macular degeneration treatment market has experienced rapid expansion in recent years. It is projected to increase from $12.38 billion in 2025 to $13.81 billion in 2026, at a compound annual growth rate (CAGR) of 11.5%. The market’s growth during previous periods can be linked to an aging global population, the rising occurrence of age-related macular degeneration, the successful clinical performance of anti-VEGF injections, improved capabilities in ophthalmic diagnostics, and greater accessibility to specialized eye care services.
The macular degeneration treatment market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $20.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. This projected growth is driven by several factors, including a global increase in the elderly population, heightened investment in cutting-edge retinal treatments, an intensified emphasis on managing early-stage age-related macular degeneration, the wider implementation of gene and regenerative therapies, and increased healthcare expenditures dedicated to vision care. Key trends anticipated during this period encompass a greater focus on prompt diagnosis and controlling disease advancement, the increasing use of anti-VEGF therapies, a rising need for treatments designed to preserve vision over the long term, the proliferation of less invasive treatment alternatives, and a heightened understanding of age-related eye conditions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp
Which Drivers Are Contributing To The Expansion Of The Macular Degeneration Treatment Market?
The rising prevalence of retinal disorders is anticipated to boost the expansion of the macular degeneration treatment market. These conditions impact crucial eye tissue, interfering with how individuals process visual information and resulting in impaired or lost sight. For instance, according to the American Academy of Ophthalmology, by 2050, an estimated 7.32 million people in the United States are projected to have primary open-angle glaucoma, a broad term for a group of eye disorders. The highest numbers are expected among populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The largest demographic within this group is Hispanic men. Therefore, the increasing burden of retinal disorders is a key factor driving the growth of the macular degeneration treatment market.
What Segment Categories Are Covered In The Macular Degeneration Treatment Market?
The macular degeneration treatment market covered in this report is segmented –
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By Route of Administration: Oral, Injectable, Other Routes of Administration
3) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
Subsegments:
1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments
2) By Intermediate AMD: Regular Disease Monitoring and Imaging Surveillance, Risk-Factor Management and Lifestyle Modification
3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options
What Industry Trends Are Transforming The Macular Degeneration Treatment Market?
Leading firms within the macular degeneration treatment market are concentrating on creating biosimilar versions of treatments for age-related macular degeneration (AMD) to enhance the availability of potent medical solutions. Biosimilars are defined as biological medicinal products that closely resemble an existing approved reference product, exhibiting no significant clinical variations in their safety, purity, or potency. An example of this trend occurred in May 2024, when Biocon Biologics Ltd, based in India, and Samsung Bioepis Co. Ltd, from South Korea, secured FDA approvals for their novel biosimilars, Yesafili and Opuviz. Both of these biosimilars function by inhibiting vascular endothelial growth factor (VEGF), a key factor in the abnormal development of blood vessels in the eye. This mechanism aids in preventing vision impairment linked to conditions such as AMD and diabetic retinopathy. The FDA’s rigorous approval process encompassed comparative studies which demonstrated that Yesafili and Opuviz possessed comparable efficacy and safety profiles to Eylea. These investigations involved thorough evaluations of the biosimilars’ pharmacokinetics and immunogenicity.
Which Leading Companies Dominate The Macular Degeneration Treatment Market Share?
Major companies operating in the macular degeneration treatment market are F Hoffmann La Roche Ltd, Regeneron Pharmaceuticals Inc, Novartis AG, Bayer AG, Allergan Inc, Bausch Health Companies Inc, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio Inc, Aerie Pharmaceuticals Inc, Kodiak Sciences Inc, Neurotech Pharmaceuticals Inc, Regenxbio Inc, Adverum Biotechnologies Inc, Applied Genetic Technologies Corp, 4D Molecular Therapeutics Inc, GenSight Biologics SA, Nanoscope Therapeutics Inc, Annexon Inc, Ocular Therapeutix Inc, Graybug Vision Inc
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Macular Degeneration Treatment Market?
North America was the largest region in the macular degeneration treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Macular Degeneration Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=5799&type=smp
Browse Through More Reports Similar to the Global Macular Degeneration Treatment Market 2026, By The Business Research Company
Retinal Disorder Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report
Macular Edema And Macular Degeneration Market Report 2026
Age Related Macular Degeneration Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
